Stanley Druckenmiller shifts portfolio toward Natera and away from megacap tech

Investor Stanley Druckenmiller, through his Duquesne Family Office, has significantly shifted his $3 billion portfolio away from megacap technology stocks, specifically reducing or exiting positions in the 'Magnificent Seven.' His most recent 13F filing shows he has completely exited Alphabet and significantly reduced his stake in Amazon.

Druckenmiller's largest single position is now Natera, a genetic testing company focused on oncology, women's health, and organ health. He increased his Natera holdings by over 550,000 shares in Q1, with the company representing approximately 18% to 21% of his total portfolio. Natera recently reported strong revenue growth, with second-quarter sales reaching $752.8 million, though the company continues to record net losses.

While avoiding major tech giants, Druckenmiller has maintained or added interest in other semiconductor and tech-related firms, including Taiwan Semiconductor Manufacturing, Broadcom, Micron, Intel, and STMicroelectronics.